Taxotere has recently been making a noticeable impact on breast, gastric, ovarian, prostate
and non-small cell lung cancers. Its side effects include dyspnea, pruritus, skin rashes, fever …

We present a patient with advanced breast cancer treated with three cycles of docetaxel who
developed repeated episodes of hypersensitivity pneumonitis, progressed to respiratory …

Background Pulmonary toxicity is a well-known complication observed with several
anticancer drugs. Docetaxel, a taxane chemotherapy drug widely used in the treatment of …

Docetaxel belongs to the taxane family of anti-cancer drugs, which are commonly used in
non-small cell lung cancers. They stabilize microtubules by preventing depolymerization …

Background: Docetaxel-induced pneumonitis is a rare, but potentially serious complication
of a commonly used chemotherapeutic agent. Methods: We performed an audit of patients …

BACKGROUND Interstitial pneumonitis has not been reported as a toxicity of docetaxel. The
authors report the presentation and natural history of four patients who developed a severe …

Taxanes are widely used chemotherapeutic agents with the potential to induce pulmonary
injury through a variety of mechanisms. Patients receiving these agents are at risk of acute …

Interstitial pneumonitis is a known, but uncommon adverse event during docetaxel therapy
in cancer patients. We report the case of a patient with breast cancer who developed a …

Docetaxel, a new chemotherapeutic agent, has demonstrated activity in non-small cell lung
cancer and breast cancer. Toxicities associated with treatment using docetaxel include …

Abstract 4 patients with advanced non-small-cell lung cancer (NSCLC) treated with
docetaxel developed life-threatening pneumonitis requiring mechanical ventilation …